Cargando…

Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey

Background. High blood pressure is a substantial risk factor for cardiovascular disease. Design & Methods. The Physicians' Observational Work on patient Education according to their vascular Risk (POWER) survey was an open-label investigation of eprosartan-based therapy (EBT) for control of...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Backer, Guy, Petrella, Robert J., Goudev, Assen R., Radaideh, Ghazi Ahmad, Rynkiewicz, Andrzej, Pathak, Atul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745839/ https://www.ncbi.nlm.nih.gov/pubmed/23997946 http://dx.doi.org/10.1155/2013/165789

Ejemplares similares

Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study
por: Goudev, Assen, et al.
Publicado: (2012)

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey
por: Petrella, Robert J, et al.
Publicado: (2014)

New Insights into the Management of Hypertension and Cardiovascular Risk with Angiotensin Receptor Blockers: Observational Studies Help Us?
por: Goudev, Assen
Publicado: (2014)

Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study
por: Radaideh, Ghazi Ahmad, et al.
Publicado: (2011)

Effects of apical right ventricular pacing on right ventricular and left ventricular mechanics in patients with preserved systolic function: 2D speckle tracking assessment
por: Poroyliev, Nikolay, et al.
Publicado: (2022)

Hiatal Hernia: The Great Masquerade in the Emergency Department
por: Borizanova, Angelina, et al.
Publicado: (2023)

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey
por: Petrella, Robert J, et al.
Publicado: (2015)

Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study
por: Bruckert, Eric, et al.
Publicado: (2022)

Comparative effectiveness of antihypertensive drugs prescribed in Ethiopian healthcare practice: A pilot prospective, randomized, open label study
por: Mengesha, Hayelom Gebrekirstos, et al.
Publicado: (2018)

Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial
por: Liu, Liping, et al.
Publicado: (2023)

Effect of antihypertensive medications on the risk of open-angle glaucoma
por: Lee, Jihei Sara, et al.
Publicado: (2023)

Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial
por: Ehrmann, Stephan, et al.
Publicado: (2021)

Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy
por: Rea, Federico, et al.
Publicado: (2023)

Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial
por: Easterling, Thomas, et al.
Publicado: (2019)

Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
por: Fleseriu, Maria, et al.
Publicado: (2019)

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial
por: Voci, Davide, et al.
Publicado: (2023)

Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia
por: Ushida, Takahiro, et al.
Publicado: (2023)

Multinational democracies /
Publicado: (2001)

Multinational corporations
Publicado: (1990)

The multinational corporation
por: Liebenau, Jonathan
Publicado: (1984)

Multinational Telecommunications
por: Collective
Publicado: (1977)

A Multicentre, Multinational, Open-Label, 52-Week Extension Study of Gemigliptin (LC15-0444) Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Yang, Sae Jeong, et al.
Publicado: (2021)

A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus
por: Pan, Changyu, et al.
Publicado: (2016)

Doing the Same with Less: A Randomized, Multinational, Open-Label, Adjudicator-Blinded Trial of an Algorithm vs. Standard of Care to Determine Treatment Duration for Staphylococcal Bacteremia
por: Holland, Thomas L, et al.
Publicado: (2017)

Expert Multinational Consensus Statement for Total Intravenous Anaesthesia (TIVA) Using the Delphi Method †
por: Uitenbosch, Giulia, et al.
Publicado: (2022)

Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation
por: Hammoudeh, Mohammed, et al.
Publicado: (2015)

Multinational business finance /
por: Eiteman, David K.
Publicado: (2001)

Multinational business finance /
por: Eiteman, David K.
Publicado: (1998)

Multinational business finance /
por: Eiteman, David K.
Publicado: (1992)

The New Mission for Multinationals
por: Santos, José
Publicado: (2015)

EEG Biofeedback Decreases Theta and Beta Power While Increasing Alpha Power in Insomniacs: An Open-Label Study
por: Wang, Huicong, et al.
Publicado: (2023)

Real electronic signal data from particle accelerator power systems for machine learning anomaly detection
por: Radaideh, Majdi I., et al.
Publicado: (2022)

Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring
por: Mobed, Ahmad, et al.
Publicado: (2023)

Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study
por: McDonnell, David P., et al.
Publicado: (2014)

Blood pressure response to commonly administered antihypertensives for severe inpatient hypertension
por: Ghazi, Lama, et al.
Publicado: (2022)

A Prospective, Randomized Open-Label Study for Assessment of Antihypertensive Effect of Telmisartan Versus Cilnidipine Using Ambulatory Blood Pressure Monitoring (START ABPM Study)
por: Sawant, Rahul, et al.
Publicado: (2023)

Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment
por: Ghazi, Lama, et al.
Publicado: (2022)

A Combined Radial and Pedal Access to Treat a Flush Chronic Total Occlusion of the Superficial Femoral Artery in a Critical Limb Ischemia Patient
por: Shammas, Nicolas W, et al.
Publicado: (2019)

Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study
por: Boughton, Charlotte K, et al.
Publicado: (2022)

The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension
por: Pawlak-Chomicka, Regina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_75reodu0dsaf788h7uh9utlgos